SG11201903100TA - Method of preparing peptides comprising a lipophilically modified lysine side chain - Google Patents
Method of preparing peptides comprising a lipophilically modified lysine side chainInfo
- Publication number
- SG11201903100TA SG11201903100TA SG11201903100TA SG11201903100TA SG11201903100TA SG 11201903100T A SG11201903100T A SG 11201903100TA SG 11201903100T A SG11201903100T A SG 11201903100TA SG 11201903100T A SG11201903100T A SG 11201903100TA SG 11201903100T A SG11201903100T A SG 11201903100TA
- Authority
- SG
- Singapore
- Prior art keywords
- co7k
- international
- sanofi
- frankfurt
- pct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16306332 | 2016-10-10 | ||
| PCT/EP2017/075773 WO2018069295A1 (en) | 2016-10-10 | 2017-10-10 | Method of preparing peptides comprising a lipophilically modified lysine side chain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201903100TA true SG11201903100TA (en) | 2019-05-30 |
Family
ID=57153433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201903100TA SG11201903100TA (en) | 2016-10-10 | 2017-10-10 | Method of preparing peptides comprising a lipophilically modified lysine side chain |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11021512B2 (de) |
| EP (1) | EP3523324B1 (de) |
| JP (1) | JP2019533666A (de) |
| KR (1) | KR20190059321A (de) |
| CN (1) | CN109790208A (de) |
| AR (1) | AR109914A1 (de) |
| AU (1) | AU2017341951B2 (de) |
| BR (1) | BR112019007063A2 (de) |
| CA (1) | CA3039752A1 (de) |
| IL (1) | IL265888A (de) |
| MX (1) | MX2019004116A (de) |
| RU (1) | RU2755543C2 (de) |
| SG (1) | SG11201903100TA (de) |
| TW (1) | TW201821434A (de) |
| WO (1) | WO2018069295A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11560402B2 (en) | 2018-04-10 | 2023-01-24 | Sanofi-Aventis Deutschland Gmbh | Method for cleavage of solid phase-bound peptides from the solid phase |
| KR20200142032A (ko) | 2018-04-10 | 2020-12-21 | 사노피-아벤티스 도이칠란트 게엠베하 | 캡핑을 사용한 릭시세나티드 합성 |
| CN110183531A (zh) * | 2019-05-17 | 2019-08-30 | 河北常山生化药业股份有限公司 | 一种艾本那肽前体的制备方法 |
| CN111704654B (zh) * | 2020-06-18 | 2021-12-03 | 上海交通大学医学院附属仁济医院 | 肽类化合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090318353A1 (en) * | 2006-08-25 | 2009-12-24 | Novo Nordisk A/S | Acylated Exendin-4 Compounds |
| RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| US8614182B2 (en) * | 2009-07-30 | 2013-12-24 | Jiangsu Hansoh Pharmaceuticals Co., Ltd. | GLP-1 analogues and their pharmaceutical salts and uses |
| CN101987868B (zh) * | 2009-07-30 | 2013-09-04 | 江苏豪森医药集团有限公司 | Glp-1类似物的衍生物或其可药用盐和用途 |
| FR2952695B1 (fr) | 2009-11-13 | 2012-03-30 | Commissariat Energie Atomique | Reservoir de stockage d'hydrogene a hydrures metalliques |
| PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
| US20130012432A1 (en) * | 2010-02-26 | 2013-01-10 | Novo Nordisk A/S | Peptides for Treatment of Obesity |
| JP5969461B2 (ja) | 2010-04-27 | 2016-08-17 | ジーランド ファーマ アクティーゼルスカブ | Ｇｌｐ−１受容体作動薬とガストリンとのペプチド複合体及びその使用 |
| CN104519902B (zh) | 2012-05-08 | 2017-10-27 | 诺和诺德股份有限公司 | 双酰化glp‑1衍生物 |
| WO2013186240A2 (en) | 2012-06-14 | 2013-12-19 | Sanofi | Exendin-4 peptide analogues |
| UA116217C2 (uk) * | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| CN104902919B (zh) | 2012-12-21 | 2018-11-20 | 赛诺菲 | Glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂 |
| TW201625669A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑 |
| TW201625670A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑 |
| TW201625668A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物 |
-
2017
- 2017-10-06 TW TW106134587A patent/TW201821434A/zh unknown
- 2017-10-10 CN CN201780062214.3A patent/CN109790208A/zh active Pending
- 2017-10-10 US US16/338,213 patent/US11021512B2/en active Active
- 2017-10-10 MX MX2019004116A patent/MX2019004116A/es unknown
- 2017-10-10 WO PCT/EP2017/075773 patent/WO2018069295A1/en active Application Filing
- 2017-10-10 SG SG11201903100TA patent/SG11201903100TA/en unknown
- 2017-10-10 EP EP17787900.4A patent/EP3523324B1/de active Active
- 2017-10-10 AU AU2017341951A patent/AU2017341951B2/en not_active Expired - Fee Related
- 2017-10-10 JP JP2019519255A patent/JP2019533666A/ja active Pending
- 2017-10-10 CA CA3039752A patent/CA3039752A1/en not_active Abandoned
- 2017-10-10 RU RU2019113729A patent/RU2755543C2/ru active
- 2017-10-10 BR BR112019007063A patent/BR112019007063A2/pt not_active Application Discontinuation
- 2017-10-10 KR KR1020197013154A patent/KR20190059321A/ko not_active Application Discontinuation
- 2017-10-10 AR ARP170102825A patent/AR109914A1/es unknown
-
2019
- 2019-04-07 IL IL265888A patent/IL265888A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200024304A1 (en) | 2020-01-23 |
| CA3039752A1 (en) | 2018-04-19 |
| AU2017341951A1 (en) | 2019-05-30 |
| AR109914A1 (es) | 2019-02-06 |
| AU2017341951B2 (en) | 2021-08-05 |
| RU2019113729A (ru) | 2020-11-13 |
| RU2019113729A3 (de) | 2021-02-20 |
| CN109790208A (zh) | 2019-05-21 |
| JP2019533666A (ja) | 2019-11-21 |
| US11021512B2 (en) | 2021-06-01 |
| RU2755543C2 (ru) | 2021-09-17 |
| EP3523324B1 (de) | 2021-09-22 |
| TW201821434A (zh) | 2018-06-16 |
| IL265888A (en) | 2019-06-30 |
| BR112019007063A2 (pt) | 2019-11-26 |
| KR20190059321A (ko) | 2019-05-30 |
| EP3523324A1 (de) | 2019-08-14 |
| MX2019004116A (es) | 2019-08-12 |
| WO2018069295A1 (en) | 2018-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201901390TA (en) | Tetracycline compounds and methods of treatment | |
| SG11201804411TA (en) | Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof | |
| SG11201408746XA (en) | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides | |
| SG11201903100TA (en) | Method of preparing peptides comprising a lipophilically modified lysine side chain | |
| SG11201811442UA (en) | Formulation of a peptide vaccine | |
| SG11201404836QA (en) | Long-acting coagulation factors and methods of producing same | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201808710UA (en) | Novel immunogenic cd1d binding peptides | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201906958TA (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201408224SA (en) | Novel ruthenium complexes, their use in the metathesis reactions, and a process for carrying out the metathesis reaction | |
| SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
| SG11201908275XA (en) | Peptides and methods for the treatment of diabetes | |
| SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins | |
| SG11201809630RA (en) | Nicotine particles | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201805191SA (en) | Yeast cell | |
| SG11201900043TA (en) | Antibody formulations | |
| SG11201900074WA (en) | Soluble fibroblast growth factor receptor 3 (sfgfr3) polypeptides and uses thereof |